I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
An Open Label Study of FT218 in Subjects With Narcolepsy
An Open Label Study to Evaluate Long-Term Safety and Tolerability of a Once Nightly Formulation of Sodium Oxybate for Extended-Release Oral Suspension (FT218) and the ability to switch from twice-nightly immediate release sodium oxybate to once-nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Subjects with Narcolepsy
somnolence
excessive daytime sleepiness
sodium oxybate
narcolepsy
sleepiness
- 0 views
- 05 Aug, 2020